SCHEMBL4822528

SCHEMBL4822528

CC(C)N1C(=O)C(C)(C)c2cc3nc(-c4n[nH]cc4NC(=O)N4CCCCC4)[nH]c3cc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.34
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
ITK Q08881 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
BRD4 O60885 1/20 0.32
RAF1 P04049 1/20 0.32
BRAF P15056 1/20 0.32
RAB9A P51151 2/20 0.31
PRSS12 P56730 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
KLK7 P49862 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4830731 1.00 KMT2A (0.34) KMT2AAURKAAURKBITKHRH4
SCHEMBL4829230 0.86 KMT2A (0.36) KMT2AAURKAAURKBHRH4RAF1
SCHEMBL4830717 0.86 KMT2A (0.36) KMT2AAURKAAURKBHRH4RAF1
SCHEMBL4822483 0.86 PDPK1 (0.37) AURKAAURKBITKBRD4PDPK1
SCHEMBL4827108 0.85 AURKA (0.52) KMT2AAURKAAURKBHRH4RAF1
SCHEMBL4822361 0.85 AURKA (0.52) KMT2AAURKAAURKBHRH4RAF1
SCHEMBL4822549 0.84 AURKA (0.53) KMT2AAURKAAURKBITKHRH4
SCHEMBL4829256 0.82 AURKA (0.38) AURKAAURKBITKBRD4KDM4E
SCHEMBL4829216 0.80 AURKA (0.37) AURKAAURKBITKBRD4PDPK1
SCHEMBL13373939 0.80 MAPT (0.46) KMT2AHRH4RAB9APRSS12KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235065-A1 Aminopyrazole derivatives HOFFMANN-LA ROCHE INC. 2006-10-19 US claimed
US-7462639-B2 e.g 3-(7,7-Dimethyl-6-oxo-1,5,6,7-tetrahydro-imidazo[4,5-f]indol-2-yl)-1H-pyrazol-4-yl]-carbamic acid benzyl ester; Aurora A (serotonin/threonine) kinase inhibitors; anticarcinogenic agent; colorectal, breast, lung, prostate, pancreatic, gastric, bladder, ovarian cancer, melanoma, neuroblastoma HOFFMANN-LA ROCHE INC. (US) 2008-12-09 US disclosed
US-20060235065-A1 Aminopyrazole derivatives HOFFMANN-LA ROCHE INC. 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235065-A1 Aminopyrazole derivatives CYP3A43, CYP3A5, CYP3A4 KMT2A 3386/4885AURKA 742/4885AURKB 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.